CorMedix Inc. Chief Financial Officer Susan Blum filed a Form 4 with the SEC on November 20, 2026, disclosing an open-market purchase of 5,000 shares of common stock on November 19, 2026.

Key Highlights

  • Reporting person: Susan Blum, Chief Financial Officer of CorMedix Inc. (NASDAQ:CRMD)
  • Transaction: Purchase (transaction code P) of 5,000 shares of common stock on November 19, 2026
  • Price paid: $4.58 per share
  • Post-transaction ownership: 129,315 shares of common stock held directly following the reported transaction
  • No derivative securities were reported as acquired, disposed of, or beneficially owned in this filing

Susan Blum's November 2026 Open-Market Purchase of CorMedix Common Stock

According to the Form 4 filed on November 20, 2026, Susan Blum, serving as Chief Financial Officer of CorMedix Inc., acquired 5,000 shares of CorMedix common stock on November 19, 2026, at a price of $4.58 per share. The transaction is coded "P," indicating an open-market purchase. The filing was submitted by Beth Zelnick Kaufman as attorney-in-fact for the reporting person.

Following the reported purchase, the filing states that Blum directly holds 129,315 shares of CorMedix common stock. The form does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as the corresponding checkbox is not marked in the filing. No derivative securities activity was reported in Table II of the form.

CorMedix Inc. is listed on NASDAQ under the ticker symbol CRMD, with the company's address listed in the filing as 389 Interpace Pkwy, Suite 450, Parsippany, New Jersey 07054. The filing covers a single transaction with a date of earliest transaction of November 19, 2026, and no amendment date is indicated, suggesting this is an original filing.

What Was Disclosed

Susan Blum, CFO of CorMedix Inc., disclosed a direct open-market purchase of 5,000 shares of common stock at $4.58 per share on November 19, 2026, bringing her directly held total to 129,315 shares, according to the Form 4 filed November 20, 2026.